期刊文献+

布舍瑞林合成工艺的优化 被引量:1

Synthesis process optimization of buserelin
下载PDF
导出
摘要 目的布舍瑞林合成工艺的优化。方法由2-Cl-CTC树酯出发合成布舍瑞林肽树脂,再经裂解、乙胺化、催化氢化、选择性脱去-Trt保护基,得到布舍瑞林。结果布舍瑞林粗肽纯度为82%。经半制备型高效液相纯化后,纯度达98%以上,总收率为37%。结论经过优化缩短了反应时间,降低了合成成本,可为工业化生产提供借鉴。 Objective To optimize the synthesis process of buserelin. Methods Using 2-CI-CTC resin synthesis of buserelin peptide resin, then by cleavage, ethylamine, hydrogenation, selective removal of the -Trt protecting group, separation and purification, synthesis of bushruilin. Results The purity of the crude peptide was more than 82%. After the purification by semi-preparative RP-HPLC, the purity was more than 98%, and the overall yield was 37%. Conclusion The process optimization can shorten reaction time, reduce the synthesis cost, which may be useful for the industrial production.
出处 《中国抗生素杂志》 CAS CSCD 北大核心 2016年第4期285-288,共4页 Chinese Journal of Antibiotics
基金 河北省海外高层次人才"百人计划"资助项目(No.E201200002)
关键词 布舍瑞林 固相合成 工艺优化 Bushruilin Solid phase synthesis Process optimization
  • 相关文献

参考文献12

  • 1琚滢蓥,徐宏伟,叶小惠,成美玲,孔毅.布舍瑞林的研究概述[J].海峡药学,2014,26(4):12-14. 被引量:6
  • 2徐峰,路杨,杨东晖,等.一种布舍瑞林的合成方法:中国,10039548.9[P].2010-6-16.
  • 3王宇,杨祺.促黄体生成素释放激素衍生物的合成方法:中国,102190709A[P].2011-09-21.(CA,2011,153:502411).
  • 4陆冬冬,乔春华,张国庆,白俊才,谈技.固液结合法合成抗肿瘤多肽药物醋酸布舍瑞林[J].中国医药工业杂志,2014,45(11):1004-1008. 被引量:4
  • 5Konig W, Geiger R, Sandow J K, et al. Peptides having LH- RT/FSH-RH activity: US, 4024248A[P]. 1977-05-17.
  • 6陈人来,李红玲,马亚平,等.一种固相制备布舍瑞林的方法[P].CN,101935339A,2011-01-05.
  • 7Ponsati O B I, Canas P M I, Jodas F G I, et al. Solid phase peptide synthesis method: EP 1179537[P]. 2008-7-30.
  • 8李红玲,袁建成,陈大来,等.一种固相制备布舍瑞林的方法:中国,101935339A[P].2013-07-03.(CA,2011,154:182860).
  • 9董倩,琚滢蓥,徐宏伟,叶小惠,成美玲,孔毅.布舍瑞林的合成制备研究[J].药物生物技术,2014,21(5):412-415. 被引量:2
  • 10Kim K M, Ryoo S J, Cha K H, et al. A method for preparing peptides using by solid phase synthesis: WO, 044890 A 1 [P]. 2008-04-16.

二级参考文献42

  • 1林浩,王德心.哌嗪二酮衍生物的合成研究进展[J].药学学报,2003,38(5):395-400. 被引量:11
  • 2艾国,程远国.长效微球注射剂及其在糖尿病治疗领域中的应用[J].中国药剂学杂志(网络版),2008(4):206-213. 被引量:5
  • 3田玲,路学智.瑞林类人工合成肽类药物的研究进展[J].中国新药杂志,2006,15(20):1723-1726. 被引量:15
  • 4杨莉,高颖昌,赵志刚.鼻腔给药的研究进展[J].中国药学杂志,2006,41(22):1685-1688. 被引量:33
  • 5武国海,周彩红,王明伟.前列腺癌治疗药物的研究新进展[J].中国新药杂志,2007,16(17):1330-1336. 被引量:4
  • 6Matta W H M,Shaw R W,Nyem. Long - term follow - up of patients with uterine fibroids after treatment with the LHRH agonist buserelin [ J ]. B JOG: An International Journal of Obstetrics & Gynaecology, 1989,96 ( 2 ) : 200 -206.
  • 7Olive D L, Pritts E A. The treatment of endometriosis[J]. Annals of the New York Academy of Sciences ,2002,955( 1 ) :360-372.
  • 8Prentice A, Deary A J,Goldbeck - Wood S,et al. Gonadotrophin - releasing hormone analogues for pain associated with endometriosis [J]. The Cochrane Library, 1999.
  • 9Falkson C I, Falkson H C, Falkson G. Effect of chemotherapy with or without buscrelin on serum hormone levels in premenopausal women with breast cancer[ J]. European Journal of Cancer and Clinical Oncol- ogy, 1991,27 (10) :1208-1211.
  • 10Huggins C, Hodges C V. Studies on prostatic cancer: 1. The effect of castration,of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate [ J ]. CA:a cancer journal for clinicians, 1972,22 (4) :232-240.

共引文献14

同被引文献9

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部